Get 20% lifetime commission for referring investors to digrin.com
here.
NeuroPace, Inc. ( NPCE) - Key Metrics
NPCE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.67 | -$0.18 | -$0.11 | -$0.12 |
| 2026Q1 | $0.65 | -$0.20 | -$0.17 | -$0.18 |
| 2025Q4 | $0.81 | -$0.08 | $0.02 | $0.01 |
| 2025Q3 | $0.83 | -$0.11 | -$0.06 | -$0.06 |
| 2025Q2 | $0.72 | -$0.26 | -$0.06 | -$0.07 |
NPCE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -22.07 |
| 2026Q1 | 0% | -16.44 |
| 2025Q4 | 0% | -47.25 |
| 2025Q3 | 0% | -23.43 |
| 2025Q2 | 0% | -10.71 |
NPCE
Price: $14.28
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 24800
Market Capitalization: 507.0 million